25th Annual Meeting of the European Charcot Foundation, November 30 till December 2, 2017, Baveno (IT)
 
Ascherio Alberto


Alberto Ascherio, MD, DrPH, is a Professor of Epidemiology and Nutrition at the Harvard T. H. Chan School of Public Health and a Professor of Medicine at the Harvard Medical School.
After graduating in medicine at the University of Milan, he practiced medicine and public health in Latin America and Africa for several years before moving to Boston, where he received a doctoral degree in epidemiology in 1992 and joined the faculty at the Harvard T.H. Chan School of Public Health.
His current research is primarily devoted to finding the causes of multiple sclerosis (MS), Parkinson disease, and amyotrophic lateral sclerosis. Among the most notable discoveries to which he has contributed is the key role of infection with the Epstein-Barr virus, vitamin D insufficiency, and cigarette smoking as risk factors for MS, the importance of vitamin D status as a determinant of MS progression, the role of caffeine consumption and urate as negative risk factors for PD, and urate elevation as a promising therapeutic strategy in PD.
He is currently conducting several investigations on risk factors for MS, Parkinson disease and amyotrophic lateral sclerosis.

Publications
Conflict of Interest form


 

Boyko Alexey


Alexei Boyko gained his MD and PhD from the Russian State Medical University, Moscow and has been Professor of the Department of Neurology and Neurosurgery at this university since 1997. He was the Chief Neurologist of the Department of Health Care of the Government of Moscow in 2001-2015, Director of the Moscow Multiple Sclerosis Center in 2004-2014 and Director of the MS Clinical and Research Center of Neuroclinic (Ysupov Hospital) since 2015. He was elected as a Honourable Professor of Kazan and Yaroslavl State Medical Universities. Professor Boyko has been a member of the "Oslo International Think-tank on Multiple Sclerosis Epidemiology, Analytical Approaches to Study of the Aetiology" at the Center for Advanced Studies of the Norwegian Academy of Science and Letters in 1994-1995, and worked at UBC MS Center in 1998 (Vancouver, Canada). He is also a member of the Presidium of the All-Russian Society of Neurologists, Co-ordinator of the Medical Consulting Boards of Moscow and All-Russian MS Societies, President of RUCTRIMS, member of ECTRIMS Council. Professor Boyko has published 14 books, 12 chapters in books and more than 750 original publications and is a co-editor of three medical journals. The main interest is epidemiology and genetic of MS, immunopathogenesis, clinical trials in MS, he is a member of several Advisory Boards of ongoing and finished clinical trials.

Publications
Conflict of Interest form



Brück Wolfgang


Wolfgang Brück has been Professor of Neuropathology and Director of the Department of Neuropathology at the University Medical Centre Göttingen, Germany, since 2002. He received his medical degree from Johannes Gutenberg University Mainz, Germany, and attained his habilitation and venia legendi for neuropathology from Georg-August University Göttingen. Wolfgang Brück’s research focusses on the immunopathology of multiple sclerosis (MS), in particular on mechanisms of lesion formation in early and progressive MS as well as on degeneration (myelin, oligodendrocytes, axons and neurons) and remyelination in MS lesions. One of the major results of his studies is the definition of different immunopathological subtypes in early multiple sclerosis. In recent years, pediatric MS became a focus of his work. The studies in human tissue are paralled by experimental studies in animal models of MS including autoimmune models in rodents and non-human primates as well as models of toxic demyelination/remyelination.

Publications
Conflict of Interest form


 

Cohen Jeffrey


Dr. Cohen is Professor of Medicine (Neurology) in the Cleveland Clinic Lerner College of Medicine. He received a BA from Connecticut College in 1976 and MD from the University of Chicago School of Medicine in 1980. He completed a Neurology Residency in 1984 then a Post-doctoral Research Fellowship in Neuroimmunology in 1987, both at the University of Pennsylvania. Dr. Cohen has worked at the Mellen MS Center at the Cleveland Clinic since 1994 and was Director 2014-2017. He also is Director of the Experimental Therapeutics Program, the Clinical Neuroimmunology Fellowship, and the MS Academic Coordinating Center. Dr. Cohen has a large clinical practice devoted primarily to the care of patients with MS and related disorders. He has over 200 publications concerning immunologic, imaging, and clinical aspects of MS. He has been involved in various capacities in a large number of clinical trials of potential therapies for MS.

Publications
Conflict of Interest form


 

Comi Giancarlo

Giancarlo Comi is Professor of Neurology, Chairman of the Department of Neurology, and Director of the Institute of Experimental Neurology at Vita-Salute San Raffaele University, Milan, Italy. He is also President of the European Charcot Foundation (ECF), a member of the Board of Administration of the Italian Multiple Sclerosis Foundation and of the Scientific Committee of Associazione Italiana Sclerosi Multipla, Co-Chair of the Scientific Steering Committee of the Progressive MS Alliance, and a fellow of the European Academy of Neurology (EAN). He has served as a past president of the European Neurology Society, the Italian Society of Clinical Neurophysiology, and the Italian Society of Neurology.

In recent years, Professor Comi has received the ‘Gh. Marinescu’ honorary award from the Romanian Society of Neurology, and has been awarded honorary memberships of the Russian Neurological Academic Society, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the European Neurological Society (ENS) and the Sociedad Espanola de Neurologia. He also received the Charcot Award for MS Research from the MS International Federation (MSIF) in 2015. Most recently, Professor Comi was awarded the Gold Medal of ‘Benemeranza Civica’ from the City of Milan.
Prof. Comi has authored and co-authored more than 1000 articles in peer-reviewed journals, and edited several books, with an h-index of 100. He has been the invited speaker for more than 450 conferences, both nationally and internationally. He sits on the executive boards of various scientific associations and on the editorial boards of Clinical Investigation, European Journal of Neurology and Multiple Sclerosis. He is also the Associate Editor of the Neurological Sciences.

Publications 
Conflict of Interest form

 



 

Cristiano Edgardo


Edgardo Cristiano graduated in Medicine in 1981 and obtained a neurologist certification in 1985. He has a fellowship in MS from the Hospital Italiano de Buenos Aires in many Centers from the USA. Currently he is Chief of the Neurology Department and Professor of Neurology at the Hospital Italiano de Buenos Aires and Assistant Professor of Neurology at the Universidad de Buenos Aires (UBA). He is Corresponding Fellow of the AAN, member of the scientific advisory board of the European Charcot Foundation, the MSBase Foundation and other national organizations. He is author and coauthor of more than 100 indexed publications, book chapters and many presentations. He was president of many international meetings and President of the last Lactrims Congress in 2016. His areas of interest are epidemiology, biomarkers and brain atrophy in MS.

Publications
Conflicts of Interest form


 

Ebers George


George Ebers is Professor Emeritus at the University of Oxford. He got his MD degree from the University of Toronto, interned at the Royal Victoria in Montreal and trained in Neurology at Cornell Medical Center in NYC where he was chief resident. He did a post doctoral fellowship in Immunology with Henry Kunkel at the Rockefeller University and was Professor at University Hospital at the University of Western Ontario. He was elected to the Chair in Neurology at the University of Oxford where he continued his research on the genetics and environment and their interactions. He has received several awards and was elected a fellow of the Academy of Medical Sciences. He now remains active at the Bayfield Institute of Medical Sciences.


Publications
Conflict of Interest form


 

Edan Gilles


Gilles Edan is currently professor of clinical neurology and chair of the Department of Neurosciences at the University Hospital of Rennes, France. After completing his MD at the University of Rennes in 1981, he went on to specialize in neurology under the supervision of Pr Olivier Sabouraud , was a research fellow at Guy’s hospital (London) in neuroimmunology with RAC Hughes in 1987, spent a sabbatical period of 6 months at the MS clinic of UBC with Don Paty and Joel Oger in Vancouver in 1996 and set up a MS clinic in Brittany in 1996. Gilles Edan was one of the members of the international panel for the new diagnostic criteria of MS (Mc Donald criteria) in 2001 and 2005. He published more than 200 peer-reviewed original papers on his MS researches in Journals and several chapters in books on these subjects.

Publications
Conflict of Interest Form


Fazekas Franz


Franz Fazekas is Professor of Neurology, head of the Department of Neurology and director of the Division of General Neurology at the Medical University of Graz, Graz, Austria.

Dr. Fazekas obtained his medical degree from Karl–Franzens University in Graz, where he also received his training in neurology and psychiatry. After a 2-year fellowship at the University of Pennsylvania, Philadelphia, USA Dr. Fazekas has focused his research on the diagnosis and treatment of multiple sclerosis and cerebrovascular diseases in combination with neuroimaging tools, especially magnetic resonance imaging (MRI).

Professor Fazekas has been President of the Austrian Society of Neurology and the Austrian Society for Stroke Research. He is also a past member of the Executive Committee of ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and of MAGNIMS (Magnetic Resonance in MS). Currently, he is a Vice President of the European Charcot Foundation and President Elect of the European Academy of Neurology (EAN). Professor Fazekas has authored more than 400 peer-reviewed papers and several book chapters, and serves on various scientific Advisory, Editorial and Review Boards. 

Publications
Conflict of Interest form


 
Fernandez Óscar


Senior Investigator of the Biomedical Research Institute of Malaga (IBIMA). Regional University Hospital of Malaga, since September 2015.
President of the Spanish Neurological Society (SEN) since 2016.
Consultant of the Neurology Section at the Regional University Hospital of Malaga since 1978 till 1991
Head of Service of Neurology (and founder) at the Regional University Hospital of Malaga since 1991 till the 28th of August 2015.
Director of the Institute of Clinical Neurosciences at the Regional University Hospital of Malaga since 2003 till the 28th of August 2015.
Degree of specialist in Neurology and Internal Medicine in 1978 (Saint Charles Clinic Hospital, Complutense University of Madrid).
PhD degree in Medicine in 1990, Faculty of Medicine of the University of Malaga.
Honorary Professor of the Faculty of Medicine of the University of Malaga since 2007.
More than 150 publications in peer review journals in the field of multiple sclerosis.
10 Projects of competitive research on multiple sclerosis, as principal investigator
More than 100 clinical trials with private/public financing.
Elaboration of 10 Guides of Clinical Practice or Consensus on multiple sclerosis diagnosis or treatment.
3 Patents.

Publications
Conflict of Interest form


 

Filippi Massimo


Massimo Filippi is currently: Full Professor of Neurology at Vita-Salute San Raffaele University, Milan, Italy; Director Residency School in Neurology, and President of the Bacherlor’s Degree in Physiotherapy at the same University; Director of the “BrainMap” Interdepartmental Program and Director of the Neuroimaging Research Unit (NRU), Department of Neurology, Institute of Experimental Neurology, Scientific Institute San Raffaele, Milan. His research activity has always focused on the definition of the mechanisms leading to progressive accumulation of irreversible physical disability and cognitive impairment in various neurological conditions. As Director of the NRU, he coordinated the MRI acquisition and analysis of several large-scale international MRI-monitored trials of MS. He is member of various national and international Scientific Societies and Boards where he covered or is covering institutional roles. He is author of over 940 papers; he is Editor-in-Chief of the Journal of Neurology and member of the Editorial Boards of many international scientific journals. He is very often requested as speaker and/or chairman in national and international neurological congresses. In 2001, Prof. Filippi was awarded the Rita Levi Montalcini Prize for his outstanding contributions to the study of MS.

Publications
Conflict of Interest form


 

Freedman Mark


Mark Freedman is Professor of Medicine (Neurology) at the University of Ottawa, Senior Scientist at the Ottawa Hospital Research Institute and Director of the Multiple Sclerosis Research Unit at the Ottawa Hospital-General Campus.

His extensive research includes molecular neurochemistry, cellular immunology, and clinical studies in MS. His basic science interest concerns immune mechanisms of damage in MS, with a particular interest in the role of the innate immune system such as gamma-delta T-cells. His main clinical interests are cell-based therapies for MS. He was the lead investigator of the Canadian Bone Marrow Transplant Study in MS and he co-heads an international study of mesenchymal stem cells for the treatment of MS. He is the current Treasurer of ACTRIMS.


Publications
Conflict of Interest form


 


Fujihara Kazuo


Kazuo Fujihara, M.D. is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama 963-8563, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He contributed to the 2010 and 2016-2017 Revisions to McDonald Criteria in the International Panel on Diagnosis of MS, and is a member of the International Panel on NMO Diagnosis. He has also served on the Board of European Charcot Foundation (2013~), the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (2013~) and an External Reviewer of Malaysian Clinical Practice Guidelines (CPG), Management of Multiple Sclerosis. He is an inaugural member and Deputy Secretary of PACTRIMS and a co-convener of “MS and Other Inflammatory Diseases” in the 23rd World Congress of Neurology (2017, Kyoto). He is a member of International Advisory Board of Sri Lankan Journal of Neurology (2012~), an Honorary Corresponding Member of the Indian Academy of Neurology (2015~), and an Honorary Fellow of the Hong Kong Multiple Sclerosis Society (2015~).

Publications
Conflict of Interest form


 

Ghezzi Angelo


Dr Angelo Ghezzi is chief emeritus of Neurology. He is the responsible of scientific research at Multiple Sclerosis Study Centre of St Antonio Abate Hospital in Gallarate, Italy, the oldest Italian MS center. He is member of the Steering Committee of the International Pediatric MS Study Group, and member of the Italian MS Study Group of the Italian Neurological Society.
Dr Ghezzi has been an active researcher, serving as an investigator in many international Phase II and III trials. His research has focused on the areas of optic neuritis, MS and pregnancy, MS and sexual disturbances, MS and epilepsy, MS evolution and prognosis, MRI and clinical correlation with MS, and clinical neurophysiology (evoked potentials, pelvic floor neurophysiology); however, he is especially interested in the clinical and therapeutic aspects of pediatric MS (MS onset in childhood-adolescence, immunomodulatory treatment of juvenile-onset MS).
Dr Ghezzi is the editor of 10 books on multiple sclerosis, and author or co-author of more than 200 articles published in international journals.

Publications
Conflicts of Interest form


Giovannoni Gavin


Gavin Giovannoni was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London and the Department of Neurology, Barts Health NHS Trust in November 2006. In September 2008 he took over as the Neuroscience Centre Lead in the Blizard Institute. Gavin did his undergraduate medical training at the University of the Witwatersrand, South Africa, where he graduated in 1987. He moved to the Institute of Neurology, Queen Square, London in 1993 after completing his specialist training in neurology in South Africa. After three years as a clinical research fellow, under Professor Ed Thompson, and then two years as the Scarfe Lecturer, working for Professor W. Ian McDonald, he was awarded a PhD in immunology from the University of London in 1998. He was appointed as a Clinical Senior Lecturer, Royal Free and University College Medical School, in 1998 and moved back to Institute of Neurology, Queen Square in 1999. He was promoted to Reader in Neuroimmunology in 2004. His clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. He is particularly interested in clinical issues related to optimising MS disease modifying therapies. His current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, defining the “multiple sclerosis endophenotype”, multiple sclerosis related neurodegeneration, multiple sclerosis biomarker discovery, multiple sclerosis clinical outcomes and immune tolerance strategies. His team focus on translational research and therefore have an active clinical trial programme.

Publications
Conflicts of Interest form


 

Hacohen Yael


Yael Hacohen is an NIHR academic clinical lecturer in paediatric neurology at University College London and Great Ormond Street Hospital, London. Yael completed her doctoral studies in 2014, in the Nuffield Department of Clinical Neuroscience (NDCN) at Oxford University, where she studied children with autoimmune encephalitis and characterised their clinical and immunological (autoantibody) phenotypes. Yael’s main research interest is the role of antibodies in paediatric CNS disorders particularly acquired demyelinating syndromes.

Publications
Conflict of Interest form


 

Hartung Hans-Peter


Professor Hartung received his undergraduate training at the Universities of Düsseldorf, Glasgow, Oxford and London. After graduation as MD in 1980 he served an immunology fellowship at the University of Mainz. He started his career in neurology at the University of Düsseldorf, where he became as-sistant professor in 1987. He was appointed professor and head of the MS clinical research group at the University of Würzburg in 1990 and moved in 1997 to Graz, Austria, to become chairman of the University Department of Neurology. He is currently chair of the Department of Neurology at Heinrich Heine University Düsseldorf, a position he has held since 2001, and since 2013 director of the Center for Neuropsychiatry. He is in charge of two busy inpatient departments with a total of 100 beds including stroke unit.

Professor Hartung’s clinical and translational research interests are in the field of basic and clinical neuroimmunology and in particular multiple scle-rosis and immune neuropathies. He has authored or co-authored more than 900 articles in peer-reviewed journals, one hundred book chapters and edited nine books.

He oversees the various research activities (clinical and preclinical) in his department that relate to Parkinson`s and movement disorders incl deep brain stimulation, stroke, neuromuscular disorders, neuro-HIV and infectious diseases, spinal cord injury, repair strategies in CNS and PNS.

He has been involved as member of the Steering Committee in numerous in-ternational multi-centre therapeutic phase 2 and 3 trials in multiple sclerosis, Guillain-Barré Syndrome and CIDP.

He was President of ECTRIMS and serves amongst others on the executive boards of the European Charcot Foundation (treasurer), the International So-ciety of Neuroimmunology, Peripheral Nerve Society, WHO Working Group on Multiple Sclerosis, GBS CIDP Foundation International, the Medical Ad-visory Board of the International (MSIF) and the German MS Society, and the US NMS Society and ECTRIMS clinical trials committee. He is member of the executive board of the International Multiple Sclerosis Cognitive So-ciety (IMSCOG). He is/ was also member of the Editorial Board of a number of international journals including Annals of Neurology, CNS Drugs, Nature Reviews Neurology, Current Opinion in Neurology, European Neurology, Journal of Neuroimmunology, Journal of Neuroinflammation (Associate Edi-tor), Journal of Neurology, Journal of Neurology Neurosurgery Psychiatry, Neurorehabilitation and Neural Repair(Associate Editor), Open Access Neu-rology, Frontiers Immunology, Frontiers Neurology (Chief Specialty Editor Multiple Sclerosis), Muscle Nerve, Therapeutic Advances in Neurological Disorders and others.

Professor Hartung is a Corresponding Fellow of the American Academy of Neurology, Fellow and general assembly member of the European Academy of Neurology, member of the management group of the EAN scientific panel on general neurology and multiple sclerosis, Corresponding Fellow of the American Neurological Association, the American Heart Association (Stroke Council), Honorary Member of the All Russian Neurological Society, Honor-ary Member of the French Neurological Society,Foreign Member of the Asso-ciation of British Neurologists and a Fellow of the Royal College of Physi-cians UK.

Publications
Conflict of Interest form


 

Hobart Jeremy


Dr. Jeremy Hobart is a Consultant Neurologist at Derriford Hospital, and Professor at the Plymouth University Peninsula Schools of Medicine and Dentistry. His clinical sub-specialist interest is the diagnosis and management of people with multiple sclerosis. His medical training was at St Mary’s Hospital Medical School in London, and neurology training was undertaken predominantly at the National Hospital for Neurology and Neurosurgery, Queen Square. He is also President of the South Devon branch of the MS Society and Consultant Neurologist to Plymouth Albion Rugby Club.

Jeremy’s research interest is rating scales for measuring health outcomes. His training in health measurement and rating scale science has included a PhD in Psychometrics from the London School of Hygiene and Tropical Medicine (Prof Donna Lamping), and post doctoral attachments to the University of Chicago (Prof Ben Wright) and, more recently, a secondment to Murdoch University Perth, Western Australia (Prof David Andrich) sponsored by a Royal Society of Medicine Ellison-Cliffe Travelling Fellowship. By a combination of chance and design, this training means that Jeremy is one of only a handful of clinicians formally trained in rating scale science. He has led the development of a number of rating scales, has published widely in this area, and holds over £10 million in research grants.


 

Kappos Ludwig


Grown up in Athens, Greece Ludwig Kappos obtained his M.D. and a Diploma in Clinical Psychology from the University of Würzburg, Germany, in 1980, where he went on to specialise in Neurology and Neuroimmunology, and became Deputy Chief, Division of Clinical Neurology, Max Planck Society, Clinical Research Unit for Multiple Sclerosis. In 1990 he was elected Head of the Outpatient Department, Neurology/Neurosurgery and since 2008 Chair of Neurology at the University of Basel, Switzerland. Research interests include immunological and molecular studies in neuroimmunological diseases, methodology and conduct of therapeutic studies mainly in the field of MS, standardisation of clinical assessment, use of magnetic resonance tomography in elucidating the pathogenesis of inflammatory CNS disease and as tool in monitoring therapeutic studies. Ludwig Kappos serves as chair or member in several steering committees and advisory boards of Clinical Trials and Organizations active in the field of MS and general Neurology. Ludwig Kappos has published more than 600 original papers, reviews and book chapters.

Publications
Conflict of Interest form


 

Kesselring Jürg


Professor of Clinical Neurology and Neurorehabilitation, University of Bern, Lecturer in Clinical Neuroscience Center of Neuroscience, University and ETH Zürich, chair of neurorehabilitation, San Raffaele University, Milano, Italy (2000-2011)
Member of the Assembly of the International Committee of the Red Cross (ICRC) www.icrc.org Fellow Royal College of Physicians (London)
First Honorary President of the Swiss Multiple Sclerosis Society 2015, President 2005 – 2011, Vicepresident 1991 – 2005; 1985 - 2001 President, 1982 1985 Secretary of the Medical Advisory Board Lifetime Honorary Board Member Multiple Sclerosis International Federation (MSIF) Honorary Visiting Professor University of Melbourne, Australia 2014, 2015 & 2016
Margrit Egnér Prize 2015 „for outstanding achievements in anthropological philosophy and psychology”
Chairman of the International Medical and Scientific Board of Multiple Sclerosis International Federation (MSIF) and of the Resarch Committee on Demyelination of the World Federation of Neurology (WFN), Chairman of the WHO Working Group on Multiple Sclerosis (1997 – 2005)
President of the European Committee on Treatment and Research in Multiple Sclerosis (ECTRIMS) 1990/91 and 1995 –1999
Honorary Senior Research Fellow: Institute of Neurology The National Hospital, Queen Square, London (1983, 1987/8, 1993, 1998)
180 Original publications and Editor or Co-Autor of 15 books, mainly related to Multiple Sclerosis, Neurorehabilitation, Magnetic Resonance Imaging. 52 book chapters on various topics

Publications
Conflict of Interest form


 

Khalil Michael


Michael Khalil is a clinical neurologist and head of the Neurology Biomarker Research Unit at the Department of Neurology at the Medical University of Graz, Austria. After his studies in medicine at Innsbruck Medical University, he was further trained in neurology at the Medical University of Graz and received his PhD at the VU University Medical Center, Amsterdam, The Netherlands. His research focuses on pathophysiologic mechanisms of neuroimmunological disorders with particular interest in Multiple Sclerosis. His main aim is to develop and validate body fluid biomarkers for disease progression, different disease phases/stages and response to disease modifying treatments. Research findings are being evaluated and interpreted in strong association with imaging (conventional and non-conventional MRI at 3T) findings of the central nervous system and detailed clinical follow-up data. This shall ultimately serve to define patient subgroups and develop more effective treatment regimens and drugs.

Publications
Conflict of Interest form

Lassmann Hans


Hans Lassmann graduated from Medical School at the University of Vienna in 1975. He then joined the Institute of Neurology of the University of Vienna for training in clinical and experimental neuropathology. He spent one year as a post doc at the Institute for Basic Research in Developmental Disabilities in New York. In 1990 he became director of the Research Unit for Experimental Neuropathology of the Austrian Academy of Science and in 1993 Professor for Experimental Neuropathology in the University of Vienna. From 1999 to 2007 he was the founding director of the Center for Brain Research of the Medical University of Vienna. He is currently Professor for Neuroimmunology at the Medical University of Vienna. He has received many research awards, including the Charcot Award (2005) of the International Federation of Multiple Sclerosis Societies for Life Long Achievement in Multiple Sclerosis Research, the Research Award (2000) of the SOBEK Foundation for outstanding research in multiple sclerosis and the K.J. Zülch Award (2010) for outstanding basic research in neurology. His current research activities concentrate on the pathogenesis of inflammatory diseases of the central nervous system with special focus on multiple sclerosis

Publications
Conflict of Interest form 


Leocani Letizia


Letizia Leocani is Associate Professor of Neurology at San Raffaele University and Supervisor of the Experimental Neurophysiology Unit and of Magnetic IntraCerebral Stimulation center. She had a PhD in Human Physiology and she has been Research Fellow at the Human Motor Control Section of the National Institutes of Health in Bethesda-USA. She is Co-Chair of the Clinical Neurophysiology scientific panel of the European Academy of Neurology. Her fields of interest involve translational validation of electrophysiological and OCT markers of neurological diseases and of treatment using non invasive brain stimulation.

Publications
Conflict of Interest form


 

Lubetzki Catherine


Catherine Lubetzki is professor of Neurology at Pierre and Marie Curie University, head of the department of Neurology and coordinator of the MS center in Salpêtrière Hospital, Paris, France. She is or has been involved in several committees and funding boards, including ECTRIMS executive committee, the scientific committee of ARSEP (French multiple sclerosis association for research), the Progressive MS Alliance Scientific Steering Committee.
Her clinical activity is mainly dedicated to the management of multiple sclerosis patients, the department of Neurology being the most important clinical center for multiple sclerosis in France, with more than 5000 patients yearly and a very active clinical research activity.
She leads, together with Pr Bruno Stankoff, a research group in the Brain and Spinal cord Institute (ICM) within the Salpetriere campus, which general aim is to develop strategies to prevent neurodegeneration and reduce disability progression in Multiple Sclerosis patients.

Publications
Conflict of Interest form


Magliozzi Roberta


Roberta Magliozzi her main research interest is to better understand the immunopathological mechanisms involved in multiple sclerosis and in particular in cortical grey matter pathology. She has paid particular attention to the inflammatory response and the role of lymphoid-like structures in the meningeal compartment of post-mortem MS tissues and in the intrathecal inflammation generated in the cerebrospinal fluid analysis of MS patients. This with the main aim to identify possible neuroimmunological mechanisms involved in multiple sclerosis and potential new biomarkers of the different disease phenotypes and of MS progression.

Publications
Conflict of Interest form


 

Miller Ariel


Prof. Ariel Miller holds a M.D. degree from the “Sackler” school of Medicine, Tel-Aviv, and a Ph.D. degree in Experimental Sciences (Neurobiology) from the Hebrew University of Jerusalem. He is a senior neurologist since 1989. From 1989 to 1992 he was a research fellow at the Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, as a scholar of the Fogarty International Research Fellowship (N.I.H.). He is currently the head of The Center for Multiple Sclerosis & Neuroimmunology Unit, at Carmel Medical Center, associated with The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Prof. Miller is elected member of the American Neurological Association (ANA) (2005), and the recipient of the Hershel Rich Technion Innovation Award – 2006, for his contribution in the field of Pharmacogenetics and 'Personalized Medicine'. He is the Founder of the Israel Society of Neuroimmunology. Prof. Miller's scientific and medical work is dedicated to elucidation of the mechanisms underlying Brain diseases, with special focus on implementation of therapeutic strategies for Multiple Sclerosis as well as Pharmacogenetics towards development of 'Personalized Medicine'.

Publications
Conflict of Interest form


 

Montalban Xavier


Dr. Xavier Montalban is Professor of Medicine and the Department Division Director, Division of Neurology, at the University of Toronto and Director of the MS Centre at St Michael’s Hospital. He is also the chair of the Department of Neurology-Neuroimmunology and Director of the Multiple Sclerosis Centre of Catalonia at the Vall d’Hebron University Hospital in Barcelona, where he is former director of the Department of Neuroscience, as well as the chief of the Neuroimmunology Research Group at the Vall d’Hebron Research Institute. He is Professor of Neurology at Universitat Autònoma de Barcelona. Dr Montalban is the President of the Cemcat Foundation. He is the chairman of the International Medical and Scientific Board of the MSIF and former President of the European Committee for Treatment and


Research in Multiple Sclerosis (ECTRIMS). Dr Montalban is a member of the International Panel on Multiple Sclerosis Diagnostic Criteria and Clinical Trials and Editor for Clinical cases of the Multiple Sclerosis Journal. He is a member of the Board of the European Charcot Foundation.

Dr. Montalban received his medical license, trained as a Neurology specialist and completed his PhD in Neuroimmunology at the Universitat Autònoma de Barcelona. He went on to undertake a postdoctoral fellowship at the Lupus Research Institute,
Guy’s & St. Thomas’ Hospital with additional clinical training at the National Hospital for Neurology and Neurosurgery, Queen Square in London, United Kingdom. For the past twenty-five years, Prof. Montalban has been in the inception phases and on steering committees of many clinical trials related to multiple sclerosis. He has authored over 500 original and revision publications in international peer-reviewed journals plus several book chapters. Recently, he co-directed the development of the first ECTRIMS-EAN Multiple Sclerosis Treatment Guidelines. His research interests include clinical trials, clinical aspects of MS, MR and biological prognostic factors of disease evolution and treatment response, immunological mechanisms of the disease and other aspects of clinical management of MS. Of note in medical education is the UAB postgraduate online Master’s Degree in Neuroimmunology (http://bit.ly/1TnD6MG) of which he is the director and professor.

In 2012 Dr. Montalban saw the culmination of over twenty years of constant strive to make MS management truly a continuous care process through the MS Centre of Catalonia (https://www.cem-cat.org/en) : a purpose built, 2000 square metre building for diagnosis, treatment, rehabilitation, research and teaching. More than 70 health care, research and other professionals power the center; together they cater for the needs of over 5,000 persons with MS and their families. Dr. Montalban will also lead a city-wide Multiple Sclerosis Program based at St. Michael’s Hospital.

Publications
Conflict of Interest form


Moser Adrian


Dr. Adrian Mathias Moser studied Medicine in Graz/ Austria and is a General Practitioner working in Preventive Medicine. He performed a postgraduate FACS-analysis course at the Karolinska Institute in Stockholm/Sweden and finished his PHD in September 2017 under the Supervision of Prof. Christoph Högenauer working with the Microbiota in immune-mediated diseases. Thereby, he focuses on the examination of mucosal immune cells of the gastrointestinal tract in patients with immune-mediated diseases and their connection to the structure and function of the gut microbiota.

Publications
Conflict of Interest form


 

Palace Jacqueline


Dr Jackie Palace is a consultant neurologist in Oxford and Associate Professor of Nuffield Department of Clinical Neurosciences, Oxford University. She leads the Oxford Multiple Sclerosis group and runs a national service for congenital myasthenia and jointly a UK neuromyelitis optica service. Her MS service comprises a regional clinical service and a clinical research group. Research interests include clinical treatment trials, immunological studies, pathology, biomarkers, genetics and imaging studies on neurodegeneration and its detection and association with inflammation. She has been a UK lead for the National Risk Sharing Scheme which assessed the long-term effectiveness for disease modifying agents in multiple sclerosis.

Publications
Conflict of Interest form


 

Sawcer Stephen


Stephen Sawcer is Professor of Neurological Genetics at the University of Cambridge and an Honorary Consultant Neurologist at Addenbrooke's Hospital. He completed a BSc in Physics at Liverpool University before going to medical school (MB ChB) at Birmingham University. He became MRCP in 1991 and FRCP in 2010. His PhD was undertaken at the University of Cambridge and was supervised by Professor Alastair Compston and Professor Peter Goodfellow. Professor Sawcer has worked on the genetics of multiple sclerosis for more than 20 years with a main focus on genomewide approaches. He is a member of the International Multiple Sclerosis Genetics Consortium (IMSGC) and the Wellcome Trust Case Control Consortium (WTCCC).

Publications
Conflict of Interest form


Scalfari Antonio


Dr Antonio Scalfari graduated in medicine in 1999 and completed his Neurology training in 2004 at the University of Messina (Italy). From 2003 to 2006, he was research fellow at Oxford University (UK), under the supervision of Professor George Ebers. From 2006 he has been working in London, UK. He obtained his PhD in neuroscience from Imperial College in 2013 and was postdoc research fellow from 2013 to 2015. His research activity involves the study of epidemiology of multiple sclerosis, its long-term evolution and clinical/radiological factors affecting its prognosis. He is currently honorary research fellow at Imperial College and was recently appointed consultant neurologist at North West London Trust Hospitals and at Imperial College Healthcare Trust Hospitals, where he manages the centre for treatment of Multiple Sclerosis and neuro-inflammatory diseases.

Publications
Conflicts of Interest form


 

Selmaj Krzysztof


Dr. Selmaj is the Professor of Neurology, Director of Neurology Center in Lodz and a Visiting Associate Professor at Albert Einstein College of Medicine, New York. He obtained the Ph.D. degree in neurology in 1983 and habilitation in 1986. Dr. Selmaj received training in neurology and neuroimmunology at the Charing Cross and Westminster Medical School, University of London, and then as an Advanced Postdoctoral Fellow of National Multiple Sclerosis Society at Albert Einstein College of Medicine, New York, where he worked between 1987 and 1993. Dr. Selmaj has been elected to serve as a vice-President of the European Federation of Neurological Societies (EFNS) in 1999-2005 and a member of International Advisory Board of the International Society for Neuroimmunology. He has served as President of the Polish Neurological Society 2008-2011, and was elected to the Executive Board of European Committee for Treatment and Research into Multiple Sclerosis (ECTRIMS). He has served for the editorial boards for European Journal of Neurology, Journal of Neuroimmunology, Archivum Immunologiae et Therapiae Experimentalis and Polish Neurology and Neurosurgery. Dr. Selmaj is a neurologist, clinical scientist and researcher. His research activity considers investigations in neurobiology and neuroimmunology with a particular interest in mechanisms of demyelination and multiple sclerosis. He published over 200 papers in the field of neurology and immunology.

Publications
Conflict of Interest form


 

Simons Mikael


Mikael Simons is a Professor for Molecular Neurobiology at the TU Munich and at the Center for Neurodegenerative Diseases (DZNE) in Munich. He is board-certified clinical neurologist with specialized expertise in neuroimmunological diseases including multiple sclerosis. The main focus is on myelin biology, an insulating membrane sheath produces by specialized glial cells. His lab combines molecular, biochemical and advanced light and electron microscopy techniques in mice and zebrafish to study how myelin is formed, maintained, and broken down in diseases. In addition, the lab works on the mechanisms of CNS regeneration and on the question of how new myelin sheaths are reformed in demyelinating diseases. The overall aim is to come up with new strategies of how to promote repair of the damaged CNS in diseases such as multiple sclerosis. Dr. Simons has been awarded the Heinz-Meier-Leibnitz Award, the EMBO Young Investigator Award, the Academia Award and the Attempto-Award of the Universties of Heidelberg and Tübingen.

Publications
Conflict of Interest form


 

Solari Alessandra


Alessandra Solari heads the Unit of Neuroepidemiology at the Neurological Institute C. Besta of Milan, Italy. Her main area of research is the validation of instruments and outcome measures (chiefly patient-reported outcome measures) for clinical, epidemiologic, and quality of care studies in neurological diseases, particularly multiple sclerosis (MS). Her other main interests are the design and conduction of randomised controlled trials on complex interventions, and shared decision making.
Member of the Scientific Committee of the Italian MS Society Foundation (FISM) from 2008, and of the European Network on Rehabilitation in MS (RIMS) Executive Board of from 2011 to 2017. From 2010 she is co-chair of the RIMS Special Interest Group ‘Patient Autonomy’. Member of the Italian Neurology Society from 1999, and of the European Academy of Neurology (EAN) from 2016, she’s leading the task force of the EAN Guideline on Palliative Care of People with Severe MS. Dr. Solari’s work has been published in over 150 peer reviewed journals and edited books. including Lancet Neurology, Neurology, Brain, Journal of Neurology Neurosurgery Psychiatry, and Multiple Sclerosis Journal.

Publications
Conflict of Interest form


 

Sorensen Per Soelberg


Per Soelberg Sorensen is Professor of Neurology at the University of Copenhagen and senior consultant at Department of Neurology, Rigshospitalet, Copenhagen. He is the founder of the Danish Multiple Sclerosis Center.
Core elements in his research include development of new MS therapies, translational and biomarker research, and he has initiated and conducted several large international trials.

He has authored more than 400 scientific publications, 353 of which are indexed in PubMed.
Professor Sorensen was Founding Editor‐in‐chief of the European Journal of Neurology from 1994 to 2003 and is currently member of the editorial board of Multiple Sclerosis Journal, European Journal of Neurology, Therapeutic Advances in Neurological Disorders, and Multiple Sclerosis and Demyelinating
Disorders.

Publications
Conflict of Interest form


Thompson Alan


Professor Alan Thompson is Dean of the Faculty of Brain Sciences at University College London, Garfield Weston Professor of Clinical Neurology and Neurorehabilitation at the UCL Institute of Neurology, a consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, and Chair of the Neuroscience Academic Medical Centre, UCLP Academic Health Sciences Centre. His main area of expertise is in the diagnosis, evaluation, and management of the progressive forms of multiple sclerosis. He has focused on the pathological mechanisms that underpin neurological disability, and on recovery through neurorehabilitation. As Dean of the Faculty of Brain Sciences he leads comprehensive programmes of research in dementia and mental health and led UCL’s successful bid for the Hub of the UK Dementia Research Institute. As Neuroscience lead for UCL Partners he has jointly led innovation in treatment pathways for stroke and brain cancer. Professor Thompson has published extensively in high-impact journals. He is chair of the Scientific Committee of the International Progressive MS Alliance, a Senior Investigator Emeritus for the National Institute for Health Research, Editor-in-Chief for Multiple Sclerosis Journal, and a Guarantor of Brain. He received his undergraduate and postgraduate degrees from Trinity College Dublin, and an honorary doctorate from Hasselt University, Belgium.

Publications
Conflicts of Interest form


 

Trojano Maria


Maria Trojano is Professor of Neurology at the University of Bari, Italy and is currently Head of the Department of Basic Medical Sciences, Neurosciences and Sense Organs and Director of the Neurology and Neurophysiopathology Units at the same University.

Professor Trojano was President (2012-2014) of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). She is Honorary Member of ECTRIMS. She is currently Member of the International Advisory Committee on Clinical Trials in MS, under the sponsorship of the US National MS Society and ECTRIMS. Since 2000 she is Chair of the Italian Multiple Sclerosis Registry. She is involved in a number of Advisory Committees on clinical trials of new agents in MS. She was member of the Education committee of the European Academy of Neurology (EAN) and of Medical and Scientific Advisory Board of Multiple Sclerosis International Federation (MSIF).
She is active in the design, implementation and analysis of phase IV clinical trials in MS and conducts basic and applied research in Neuroepidemiology and Neurochemistry/Neuroimmunology.

She has published over 300 original contributions in the MS field on international journals and has authored a large number of book chapters. 

Publications
Conflict of Interest form 


Uitdehaag Bernard M. J.


Prof. dr. Bernard M.J. Uitdehaag (1958) studied medicine in Nijmegen and was trained in neurology in Amsterdam. In Amsterdam he was also trained in epidemiology.
He is involved in MS research since 1985 end did his PhD in MS research in 1998.
In 2009 he became a professor of neuro-epidemiology and in 2010 chair of the department of Epidemiology and Biostatistics in the VU University Medical Center in Amsterdam.
In 2013 he became professor of Neurology and chair of the Department of Neurology in the VU University Medical Center in Amsterdam. In 2013 he also became Director of the VUmc MS Center Amsterdam.
Between 2006 and 2014 he was member of the Netherlands Society of Neurology, being president from 2011 until 2014.
He (co-)authored around 300 scientific papers.

Publications
Conflicts of Interest form


van Eikema Hommes Otto R.
Vermersch Patrick


Patrick Vermersch studied medicine at the University Hospital in Lille, where he graduated in neurology. He then completed his education in more basic research fields, mainly in cellular biology between 1990 and 1994 with a PhD focused on biochemical abnormalities associated with Alzheimer’s and other neurodegenerative diseases. He has also conducted research related to the characterisations of post-transcriptional anomalies of Tau proteins. His research interests then turned to multiple sclerosis (MS).
Prof. Vermersch is head of one of the departments of neurology at the University of Lille, which deals with MS and other neuroinflammatory diseases. The department’s principal scientic interests are neuroimmunology and markers of disease evolution.

Prof. Vermersch is currently vice-dean of the faculty of medicine at the University of Lille. In the year 2000, he created with colleagues the first MS network in northern France to improve both care and research into MS. His current areas of interest are prognostic markers of MS and neuroimmunology in general. He participates in many therapeutic protocols on MS. He has published approximately 360 scientific papers as author or co-author.

Conflict of Interest form

 

Wekerle Hartmut


Hartmut Wekerle completed his medical studies in Freiburg, Germany. After his postdoctoral training in the department of cell biology, Weizmann Institute (Israel) and work as senior scientist at the MPI for Immunobiology, Freiburg, he built up and directed the Clinical Research Unit of Multiple Sclerosis Research of the Max Planck Society in Würzburg (1982-1989). From 1988 - 2012 he has been member of the Max Planck Society and director at the MPI of Neurobiology, Martinsried. From 1999 - 2002 he was in charge as Chairman (Dean) of the Biological-Medical Section, (Faculty) of the Max-Planck-Society. He is currently incumbent of a HERTIE Senior Professorship and leads an extended emeritus research group. Hartmut Wekerle has received several scientific awards, among them the Jung Prize for Science and Research (1982), Zülch Prize (1999), the Charcot Award of the MS International Federation (2001), the Louis D Award (Grand Prix des Academies des Sciences, Paris, 2002) and the Betty and David Koetser Award (2005). He is Honorary Professor at the LMU (University of Munich), Honorary Doctor (Medical Faculty of the University of Hamburg and University of Würzburg), Member of the German Academy of Sciences (Leopoldina) and Honorary Member of the Société Francaise de Neurologie.

Publications
Conflict of Interest form